Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. — CFSMEATLAS
Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis.
Nelson, Maximillian J, Bahl, Jasvir S, Buckley, Jonathan D et al. · Medicine · 2019 · DOI
Quick Summary
This study looked at how the hearts of people with ME/CFS respond differently compared to healthy people, focusing on heart rate and its patterns. Researchers reviewed 64 previous studies and found that ME/CFS patients tend to have higher resting heart rates, unusual heart rate responses to position changes, and different patterns in heart rate variability (the natural variation in time between heartbeats). These findings suggest that the nervous system that controls heart function may work differently in people with ME/CFS.
Why It Matters
These findings provide objective, quantifiable evidence that autonomic nervous system dysfunction is present in ME/CFS, which could support diagnosis and help validate the biological basis of the condition. Understanding these cardiac autonomic alterations may inform treatment strategies and help distinguish ME/CFS from other conditions with similar symptoms.
Observed Findings
Resting heart rate was 4.14 bpm higher in ME/CFS patients compared to controls.
Heart rate response to head-up tilt testing was significantly exaggerated in ME/CFS patients.
Maximal heart rate during exercise was 13.81 bpm lower in ME/CFS patients.
Orthostatic heart rate response (change upon standing) was elevated in ME/CFS patients.
Inferred Conclusions
ME/CFS patients demonstrate consistent alterations in cardiac autonomic regulation compared to healthy controls.
These autonomic differences are detectable across multiple heart rate parameters and assessment conditions.
Altered HR parameters may serve as biomarkers or objective measures of autonomic dysfunction in ME/CFS.
Cardiac autonomic dysfunction appears to be a characteristic feature of ME/CFS physiology.
Remaining Questions
Do these autonomic alterations correlate with symptom severity or specific symptom clusters in ME/CFS?
Are the observed cardiac autonomic changes reversible with treatment, or do they persist regardless of clinical outcomes?
What This Study Does Not Prove
This study does not prove that autonomic dysfunction causes ME/CFS or that it is the primary mechanism underlying the condition—it only shows an association. The findings are based on compiled existing research with varying methodologies, so they cannot establish whether these cardiac changes are specific to ME/CFS or present in other conditions. Additionally, altered heart rate parameters may be a symptom of the condition rather than a cause.